These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26628468)

  • 1. Reply to M.C. Chamberlain.
    Taphoorn MJ
    J Clin Oncol; 2016 Jan; 34(3):292. PubMed ID: 26628468
    [No Abstract]   [Full Text] [Related]  

  • 2. Similar Trials With Differing Outcomes: Reconciliation in Glioblastoma.
    Chamberlain MC
    J Clin Oncol; 2016 Jan; 34(3):291-2. PubMed ID: 26628477
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to T.J. Kruser et al.
    Chinot OL; Taphoorn MJ; Bais C; Bourgon R; Phillips HS; Abrey LE; Wick W; Mason W; Henriksson R; Saran F; Nishikawa R; Cloughesy T
    J Clin Oncol; 2016 Apr; 34(11):1282-3. PubMed ID: 26884575
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuro-oncology: What is the optimal use of bevacizumab in glioblastoma?
    Desjardins A
    Nat Rev Neurol; 2015 Aug; 11(8):429-30. PubMed ID: 26195258
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of Patients Who Benefit From Bevacizumab in High-Grade Glioma-An Easy Question Turned Difficult: Treat the Scan or the Patient?
    Kruser TJ; Mehta MP; Kozak KR
    J Clin Oncol; 2016 Apr; 34(11):1281-2. PubMed ID: 26884565
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bevacizumab associated with radiotherapy and temozolomide as a first line treatment for high-grade gliomas: one answer but too many questions].
    Lebrun-Frenay C
    Rev Neurol (Paris); 2014 Apr; 170(4):235-6. PubMed ID: 24776742
    [No Abstract]   [Full Text] [Related]  

  • 7. Health-Related Quality of Life in a Randomized Phase III Study of Bevacizumab, Temozolomide, and Radiotherapy in Newly Diagnosed Glioblastoma.
    Taphoorn MJ; Henriksson R; Bottomley A; Cloughesy T; Wick W; Mason WP; Saran F; Nishikawa R; Hilton M; Theodore-Oklota C; Ravelo A; Chinot OL
    J Clin Oncol; 2015 Jul; 33(19):2166-75. PubMed ID: 26014298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of concurrent radiation therapy, temozolomide, and bevacizumab followed by bevacizumab/everolimus as first-line treatment for patients with glioblastoma.
    Hainsworth JD; Shih KC; Shepard GC; Tillinghast GW; Brinker BT; Spigel DR
    Clin Adv Hematol Oncol; 2012 Apr; 10(4):240-6. PubMed ID: 22706484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avastin: more questions than answers. .
    Desjardins A; Sampson JH
    J Neurosurg; 2012 Feb; 116(2):336-40; discussion 340. PubMed ID: 22035270
    [No Abstract]   [Full Text] [Related]  

  • 10. Taming glioblastoma by targeting angiogenesis: 3 years later.
    Wong ET; Brem S
    J Clin Oncol; 2011 Jan; 29(2):124-6. PubMed ID: 21135277
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential usefulness of radiosensitizers in glioblastoma.
    Harasaki Y; Waziri A
    Neurosurg Clin N Am; 2012 Jul; 23(3):429-37. PubMed ID: 22748655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked functional improvement after combined chemoradiotherapy for cervical spine glioblastoma causing quadriparesis in an adolescent.
    Lau PK; Lee G; Bynevelt M; Nowak AK
    BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24518393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bevacizumab for glioblastoma multiforme after traumatic subarachnoid hemorrhage.
    Lukas RV; Goldenberg F; Nicholas MK
    J Clin Neurosci; 2012 Sep; 19(9):1310-1. PubMed ID: 22721885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment for Patients With Newly Diagnosed Glioblastoma--Reply.
    Stupp R; Toms SA; Kesari S
    JAMA; 2016 Jun; 315(21):2348-9. PubMed ID: 27272591
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term Results of a Survey of Prolonged Adjuvant Treatment with Temozolomide in Patients with Glioblastoma (SV3 Study).
    Rivoirard R; Falk AT; Chargari C; Guy JB; Mery B; Nuti C; Peoc'h M; Forest F; Garin C; Adjabi A; Hoarau D; Kawaye S; Almokhles H; Fournel P; Magné N
    Clin Oncol (R Coll Radiol); 2015 Aug; 27(8):486-7. PubMed ID: 25963856
    [No Abstract]   [Full Text] [Related]  

  • 16. Can We Predict Bevacizumab Responders in Patients With Glioblastoma?
    Mayer TM
    J Clin Oncol; 2015 Sep; 33(25):2721-2. PubMed ID: 26195699
    [No Abstract]   [Full Text] [Related]  

  • 17. Bevacizumab for newly diagnosed glioblastoma.
    Chinot OL; Wick W; Cloughesy T
    N Engl J Med; 2014 May; 370(21):2049. PubMed ID: 24860870
    [No Abstract]   [Full Text] [Related]  

  • 18. Bevacizumab for newly diagnosed glioblastoma.
    Haines IE; Gabor Miklos GL
    N Engl J Med; 2014 May; 370(21):2048. PubMed ID: 24849089
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of Glioblastoma.
    Nam JY; de Groot JF
    J Oncol Pract; 2017 Oct; 13(10):629-638. PubMed ID: 29020535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Survival benefit from the addition of bevacizumab to first-line radiochemotherapy for the treatment of proneural glioblastoma?].
    Seidel C; Kortmann RD
    Strahlenther Onkol; 2016 Jan; 192(1):65-6. PubMed ID: 26560703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.